http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2238768-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a673a2bdadfb7df0731a31d650002710 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cccbab6b4ff37031b5900410e218b965 |
| publicationDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2238768-C1 |
| titleOfInvention | Method for treating gestosis |
| abstract | FIELD: medicine, obstetrics. n SUBSTANCE: additionally to conventional therapy it is necessary to carry out seances of aeroionotherapy at the dosage of 18-24 БЕА daily for 10-14 d simultaneously with intravenous injection of an antioxidant as mexidol by drops at the dosage of 100-200 mg/d, and subcutaneously as an anticoagulant - fraxiparine at the dosage of 0.3-0.6 ml once daily for 5-7 d. The present innovation provides prolonged pregnancy by 2-4 wk on an average, decreased number of premature deliveries and birth of babies at low body weight due to decreased activity of lipid peroxidation processes and normalization of hemostatic processes. n EFFECT: higher efficiency of therapy. n 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2467722-C1 |
| priorityDate | 2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.